MAKING A TRANSFORMATION STORY STICK: HOW LEADERS CONVERT STRATEGY INTO ACTION
Leader to Leader · 18.11.2026
DOI: 10.1002/ltl.70100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leader to Leader, online erschienen am 18.11.2026. Verfasst von Constantine Alexandrakis.
Abstract (Originalsprache)
The author, Chief Executive Officer of Russell Reynolds Associates, a global leadership advisory firm, writes about the intricacies of organizational transformations, particularly by CEOs/Chief Executive Officers. He relates the concept of the Catalyst CEOs, “who successfully translate their transformation vision into results.” For creating a transformation story that scales, he writes about three things to do (what he calls moves), which in his words are: (1) make the story legible (2) make the story repeatable, and (3) pace the story so that it can be absorbed. These moves are necessary partly because his company's research found that “just 32% of leaders globally believing that their executive team communicates effectively with the organization.” Within move 1 he relates an anecdote about what he learned from a trusted colleague about his own instances of ineffective communication. Within move 2, he writes that “when people hear the same ideas expressed consistently over time, they stop treating them as messaging and start using them as tools for decision‐making.” Within move 3: “Leaders define what must happen now, how success will be recognized, and when one chapter ends, and the next begins.”
Zitieren
APA
Alexandrakis, C. (2026). MAKING A TRANSFORMATION STORY STICK: HOW LEADERS CONVERT STRATEGY INTO ACTION. Leader to Leader. https://doi.org/10.1002/ltl.70100
Vancouver
Alexandrakis C. MAKING A TRANSFORMATION STORY STICK: HOW LEADERS CONVERT STRATEGY INTO ACTION. Leader to Leader. 2026. doi:10.1002/ltl.70100
BibTeX
@article{Alexandrakis2026,
author = {Alexandrakis, Constantine},
title = {MAKING A TRANSFORMATION STORY STICK: HOW LEADERS CONVERT STRATEGY INTO ACTION},
journal = {Leader to Leader},
year = {2026},
doi = {10.1002/ltl.70100}
}
EUVIMED